<?xml version="1.0" encoding="UTF-8"?>
<ref id="R25">
 <label>25.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bartolucci</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Verdugo</surname>
    <given-names>FJ</given-names>
   </name>
   <name>
    <surname>Gonz√°lez</surname>
    <given-names>PL</given-names>
   </name>
   <name>
    <surname>Larrea</surname>
    <given-names>RE</given-names>
   </name>
   <name>
    <surname>Abarzua</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Goset</surname>
    <given-names>C</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy])</article-title>
  <source>
   <italic>Circ Res.</italic>
  </source>
  <year>2017</year>
  <season>Oct 27</season>
  <volume>121</volume>
  <issue>10</issue>
  <fpage>1192</fpage>
  <lpage>1204</lpage>
  <pub-id pub-id-type="pmid">28974553</pub-id>
 </element-citation>
</ref>
